Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

NCT02721966 ·Status: COMPLETED ·Phase: PHASE3

Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloarthritis (pSpA).

NCT05206591 ·Status: WITHDRAWN ·Phase: PHASE3

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

NCT00809159 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

NCT03502616 ·Status: COMPLETED ·Phase: PHASE3

A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

NCT06860750 ·Status: RECRUITING ·Phase: PHASE3

16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis

NCT01358175 ·Status: COMPLETED ·Phase: PHASE3

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis

NCT02294227 ·Status: COMPLETED ·Phase: PHASE3

A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission

NCT05622708 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

NCT06222671 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants

NCT06115967 ·Status: COMPLETED ·Phase: PHASE1

A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

NCT01709656 ·Status: COMPLETED ·Phase: NA

Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

NCT01752634 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

NCT00265083 ·Status: COMPLETED ·Phase: PHASE3

Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.

NCT01770379 ·Status: TERMINATED ·Phase: PHASE3

A Study of CC-99677 in Participants With Active Ankylosing Spondylitis

NCT04947579 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

NCT04169373 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

NCT05198310 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT04204603 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis

NCT04732117 ·Status: COMPLETED ·Phase: PHASE3

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

NCT00413660 ·Status: COMPLETED ·Phase: PHASE2

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)

NCT03259074 ·Status: COMPLETED ·Phase: PHASE3

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

NCT01426789 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis

NCT03798028 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis

NCT04840485 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

NCT06913907 ·Status: RECRUITING ·Phase: PHASE4